Showing results (961-970 of 1,376) with videos related to

Sort By:
Pageof 138
Neuro-Oncology Advances|April 10, 2024
Advancing noninvasive glioma classification with diffusion radiomics: Exploring the impact of signal intensity normalizationMartha Foltyn-Dumitru, Marianne Schell, Felix Sahm, et al.
Neuro-Oncology Advances|January 30, 2024
De Ritis ratio in elderly glioblastoma patients treated with chemoradiation: A comprehensive analysis of serum biomarkersJina Kim, Hye In Lee, In Ah Kim, et al.
Neuro-Oncology Advances|January 22, 2024
Challenges and limitations of clinical trials in the adolescent and young adult CNS cancer population: A systematic reviewEmma M Byrne, Maeve Pascoe, Diane Cooper, et al.
Neuro-Oncology Advances|February 5, 2024
Differences in methylation profiles between long-term survivors and short-term survivors of IDH-wild-type glioblastomaMatthijs van der Meulen, Ronald C Ramos, Mathew R Voisin, et al.
Neuro-Oncology Advances|January 30, 2024
Molecular prognostication in grade 3 meningiomas and p16/MTAP immunohistochemistry for predicting CDKN2A/B statusKira Tosefsky, Karina Chornenka Martin, Alexander D Rebchuk, et al.
Neuro-Oncology Advances|February 5, 2024
Corrigendum to: Surgery versus radiosurgery for vestibular schwannoma: Shared decision making in a multidisciplinary clinic
Neuro-Oncology Advances|September 6, 2024
A systematic review of normal tissue neurovascular unit damage following brain irradiation-Factors affecting damage severity and timing of effectsAnnet Nakkazi, Duncan Forster, Gillian A Whitfield, et al.
Neuro-Oncology Advances|September 2, 2024
Glioma-related epilepsy following low-grade glioma surgeryAmir Saam Youshani, Calvin Heal, Jing X Lee, et al.
Neuro-Oncology Advances|August 30, 2024
Analysis of the discontinuation and nonpublication of neurooncological randomized clinical trialsMolly Butler, Mehul Mehra, Abdullah Chandasir, et al.
Neuro-Oncology Advances|October 7, 2024
Correction to: Effect of bevacizumab on refractory meningiomas: 3D volumetric growth rate versus response assessment in neuro-oncology criteria
Pageof 138